Aplt purchasers have opportunity to lead applied therapeutics, inc. securities fraud lawsuit

New york , jan. 31, 2025 /prnewswire/ --  why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of applied therapeutics, inc. (nasdaq: aplt) between january 3, 2024 and december 2, 2024, both dates inclusive (the "class period"), of the important february 18, 2025 lead plaintiff deadline. so what: if you purchased applied therapeutics securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
APLT Ratings Summary
APLT Quant Ranking